CJC-1295 DAC vs No DAC: A Research Comparison
6 min read · For research use only
CJC-1295 is available in two research forms that differ by a single feature: the Drug Affinity Complex, or DAC. Choosing between them is one of the most common questions in growth-hormone-axis research. This article compares CJC-1295 with DAC vs no DAC for laboratory research only. It is not medical advice, and the compound is not for human or animal use.
What the DAC Changes
Both forms are growth-hormone-releasing hormone (GHRH) analogs based on the GHRH(1-29) sequence and engage the same receptor. The difference is duration:
- CJC-1295 No DAC (often called Modified GRF 1-29) is the short-acting form. In models it produces a brief, pulsatile signal, which suits research where a short, well-defined stimulus is desired.
- CJC-1295 With DAC carries a Drug Affinity Complex that binds serum albumin, substantially extending its half-life in models to a duration measured in days. This suits research into sustained exposure rather than pulsatile signaling.
Choosing a Form for Research
The decision follows the research question. Studies modeling natural pulsatile release, or pairing a GHRH analog with a short-acting GHRP, often use the No DAC form, see ipamorelin vs CJC-1295. Studies of prolonged, steady exposure often use the DAC form. Neither is inherently superior; they answer different questions.
Handling and Quality
Both forms are supplied lyophilized and verified to at least 99% purity by third-party HPLC and mass spectrometry with a batch certificate of analysis. See CJC-1295 With DAC mechanism of action and CJC-1295 No DAC mechanism of action for detail.
Common Research Questions
Is DAC or No DAC better for research? Neither is universally better. No DAC suits short, pulsatile-signal models; With DAC suits sustained-exposure models. The research question decides.
What does 'Mod GRF 1-29' refer to? Modified GRF 1-29 is another name commonly used for the No DAC form of CJC-1295, the short-acting GHRH(1-29) analog.
Summary
The DAC extends duration; No DAC keeps the signal short and pulsatile. Explore CJC-1295 With DAC and CJC-1295 No DAC, both research use only.
Referenced compound
CJC-1295 With DAC 5mg →Long-acting GHRH analogue with Drug Affinity Complex, studied in GH-axis pulsatility research. Lyophilized.
Related reading
For research use only. Not for human or veterinary use. Content is provided for laboratory research and educational purposes.
